Observational studies have shown that some of the classic CV risk factors, namely hypertension or hypercholesterolemia, become nebulous, or even act in the reverse direction, in the oldest people. We investigated whether in the elderly, increased aortic stiffness was associated with higher mortality risk, before and after adjustments on common geriatric confounders. In a cohort of 331 (86 men) subjects aged 470 years (mean age ( ± s.d.): 85 ± 7 years), aortic stiffness was assessed by carotid-femoral pulse wave velocity (PWV). Classical CV risk factors were determined simultaneously, in association with inflammation and denutrition parameters. One hundred and ten subjects died during a 2-year follow-up period. In crude analysis, a positive non-significant trend was observed between PWV and mortality risk. Multivariate Cox regression analysis showed that five parameters entered the prediction model: two were positively related to mortality risk, PWV (P ¼ 0.008) and orosomucoide (P ¼ 0.045), and three were related negatively, total cholesterol (P ¼ 0.006), albumin (P ¼ 0.026) and body weight (P ¼ 0.035). Interaction analysis revealed that the effect of PWV on mortality was increased in the presence of renal dysfunction and increased inflammation. In conclusion, although marginally significant in crude analysis, PWV is a powerful determinant of prognosis in the oldest people taking into account inflammation and denutrition.
Introduction
Aging of the arterial system is accompanied by structural changes, including fragmentation and degeneration of elastin, increases in collagen, thickening of the arterial wall and progressive dilation of the arteries. These changes result in a gradual stiffening of the vasculature and an increase in the velocity of the pressure wave as it travels down the aorta. In a normal elastic aorta, the pressure wave reflects from the periphery and returns to the heart during diastole. Thus, it increases coronary perfusion during diastole. As the aorta stiffens, the velocity of the pressure wave increases, and the reflected pressure wave eventually reaches the heart at systole instead of diastole, causing augmentation of the systolic blood pressure (SBP) and increased cardiac afterload. The diminished elastic recoil of the stiff aorta, combined with the absence of diastolic augmentation from the reflected pressure wave, has the potential to reduce coronary filling. 1, 2 With increasing age, there is a gradual shift from diastolic BP (DBP) to SBP and then to pulse pressure (PP) as predictors of cardiovascular (CV) risk, mainly from coronary heart disease. In patients o50 years of age, DBP is the strongest CV predictor. The age range of 50-59 years is a transition period when all three BP indices are comparable predictors, and, from 60 years of age, PP becomes superior to both SBP and DBP to predict myocardial infarction. 3 In addition, because for a given ventricular ejection aortic stiffness is the major determinant of PP, increased aortic pulse wave velocity (PWV), a classic marker of arterial rigidity, has also been identified as an independent predictor of CV risk in numerous populations. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] Only three studies took place in the elderly; 7, 13, 16 none was specifically designed to test the multi-adjusted added value of aortic PWV in term of all-cause mortality prediction. Finally, very few studies addressed the potential validity of thesepathophysiological considerations in the frail oldest old with a high burden of CV disease.
In the present study, a cohort of very old frail subjects (mean age (±s.d.): 85±7 years) was investigated prospectively. We tried to delineate the role of aortic PWV on total mortality, after taking into consideration specific geriatric confounders, namely inflammation and denutrition. l) were not included in the study.
Methods

Study cohort
The PROTEGER Study has been described in detail elsewhere; [17] [18] [19] briefly, the study cohort was then composed of 331 subjects (86 men and 245 women) with mean age ( ± s.d.) of 85 ± 7 years. The PROTEGER study was approved by the Committee for the Protection of Human Subjects in Biomedical Research of Saint Germain Hospital (Ile de France), and by the CNIL. Written informed consent was obtained from all participants, after information of themselves and of their relatives. Only the parameters, which were relevant to the present analysis, are presented here.
Collection of baseline data
Information compiled from the questionnaire filled out at inclusion included gender, age, anthropometric markers, personal history of CV event, the presence of diabetes mellitus, dyslipidemia, hypertension, smoking habits and previous diseases. The reason for hospitalization and the level of education were also registered.
In all cases, such information agreed with that given by relatives and/or recorded from the most recent previous hospitalization.
Because some patients were not able to stand up, height was estimated for all patients from the knee height as described previously by Chumlea et al.: 20 Height ¼ 78.31 þ (1.94 knee height (cm))-(0.14 Â age (years)) for men; and Height ¼ 82.21 þ (1.85 knee height (cm))-(0.21 Â age (years)) for women. BMI (kg m À2 ) was calculated as body weight/(estimated height) 2 . Body composition (fat mass) was measured, for patients able to stand up, by using the Tanita DC-320 (Tanita Corp., 232 Tokyo, Japan) BIA device based on four separate foot-pad electrodes mounted on the system's base, 21 with subjects in indoor clothing and no shoes.
Medications
Antihypertensive drugs included the following: diuretics (38.0%), calcium channel antagonists (27.9%), angiotensin-converting enzyme inhibitors (26.1%), b-blockers (12.3%), a-blockers (4.0%), central-acting agents (3.1%), either alone or in combination. Three percent of the patients were medically treated for dyslipidemia (drugs including statins or fibrates), and 14 percent of the patients were medically treated for diabetes mellitus (drugs including sulfonamides and/or biguanids, and/or insulin).
Assessment of BP and arterial stiffness
The measurements were performed in the morning, after an overnight fast, each patient being in supine position. Brachial BP was measured after 15 min of rest, by using the semi-automatic oscillometric device, Dynamap (KONTRON, Paris, France). Five measurements 2 min apart were averaged. Data on the validity of the oscillometric devices in the elderly, and especially in the presence of increased levels of arterial stiffness, are lacking, therefore our results should be viewed under this limitation.
Aortic PWV was determined by using the foot-tofoot method as described previously 22 (Complior, Colson, Paris); it was available in n ¼ 283 subjects. The superficial distance covered by the pulse wave was measured directly from the carotid to the femoral artery. This method for distance assessment may overestimate PWV by approximately 2 m s À1 on average. 23 
Measurement of biological parameters
Venous blood samples were obtained in subjects after an overnight fast. Plasma was separated without delay at 4 1C in a refrigerated centrifuge and stored at 4 1C (for the determination of routine chemistry profile by standard methods) until analysis. Total cholesterol and triglycerides were determined by using a Technicon Chem assay (Technicon Instruments, Elkhart, IN, USA), and high-density lipoprotein cholesterol was measured in the supernatant after precipitation of apolipoprotein-B-containing lipoproteins with heparin-manganese chloride. Plasma creatinine concentration (Hitachi 911 analyzer with Roche reagents) was measured. Plasma albumin and orosomucoid were determined by immunonephelometric methods by using the Immage system (Beckman Coulter, Villepinte, France). Creatinine clearance was assessed according to both the Cockcroft and Gault 24 Aortic stiffness and death in the oldest J Blacher et al and the Modification of Diet in Renal Disease (MDRD) formula. 25 Follow-up procedures Follow-up started from the baseline examination and lasted until April 2004. Of all 331 participants in the present study, three (1%) were lost to followup. Information was obtained from the patient himself/herself, from relatives or from general practitioners. Interim telephone and clinic contacts were used to assess all hospitalizations and outpatient CV diagnoses, and overall mortality. In case of hospitalization, discharge reports from medical specialists were obtained. Fatal and non-fatal CV events, and all-cause mortality, were reported. Follow-up time was defined by the time from the baseline visit until the first event date (for those who had an event), or was censored at the last contact date (for those who did not have any event or for the three patients that were lost to follow-up).
Statistical analysis
In this exploratory analysis, subjects' characteristics were compared according to mortality event by Student's t-test for normal continuous data and w 2 -test for qualitative data. Martingale residuals analysis has been used to assess the proportional hazards assumption over time of a Cox model. A Cox regression model was used to determine the independent predictors of total mortality. The best model verified by the last stepwise method (entering level ¼ 0.10, removing level ¼ 0.05) contains five characteristics weight, PWV, albumin, orosomucoïd and cholesterol. Tests for interaction were performed by likelihood ratio test of models with and without interaction terms.
For testing the different interactions (2 by 2 only because of power), the population was divided into two groups (low-value/high-value) for each variable entering the multivariate Cox regression model, and each interaction was tested by introducing in the model the interaction terms 1 by 1 (that is, PWV Â creatinine).
Statistical analyses were performed by using the SAS software (version 9.1; SAS Institute, Cary, NC, USA). A two-tailed Po0.05 was considered significant.
Results
Baseline characteristics of study participants
The population was composed of 331 patients (86 men and 245 women), with a mean age±s.d. of 85±7 years. At inclusion, 75% of the patients were hypertensive, 32% had a history of clinical heart failure and 79% were at the stage of CV secondary prevention (coronary heart disease or cerebrovascular disease, or peripheral arterial disease).
After a mean follow-up of 14 months, 110 subjects (33%) were deceased. Table 1 compares the general clinical and hemodynamic parameters of the deceased versus the surviving subjects at the end of follow-up. Older age, lower weight and low DBP were significantly associated with death. Personal CV history did not affect the incidence of mortality at the end of followup: There was no statistical difference in mortality whether the patients had a history of coronary heart disease, stroke or heart failure, or another CV past event (data not shown). Traditional CV risk factors were not significantly different in the deceased than in the surviving group, except for diabetes mellitus. In Table 2 , we show that total and low-density lipoprotein cholesterol, hemoglobin, creatinine clearance and plasma albumin levels were significantly lower (Po0.001), and plasma creatinine and orosomucoid levels were higher (Po0.01), in the deceased group by comparison with survivors. 
Models predicting survival by Cox regression analysis
In crude analysis, a positive non-significant trend was observed between PWV and mortality risk. Multivariate Cox regression analysis showed that five parameters entered the prediction model (with creatinine being marginally significant (P ¼ 0.07)): Two were positively related to mortality risk, PWV (P ¼ 0.008) and orosomucoide (P ¼ 0.045), and three were related negatively, total cholesterol (P ¼ 0.006), albumin (P ¼ 0.026) and body weight (P ¼ 0.035) ( Table 3) . It is important to note that age was initially the strongest parameter in the model, but after entering other variables by a stepwise forward procedure, the level of significance of this parameter progressively decreased and was finally no more statistically significant in the last models building procedures. This was partially due to an intercorrelation between age and other parameters, namely weight.
A significant interaction (Po0.05), between the presence of renal dysfunction and aortic stiffness on the one hand, and between the presence of increased inflammation and aortic stiffness on the other hand, regarding their effect on mortality, was observed when their product was introduced in the Cox regression model, indicating that the effect of PWV on mortality was increased in the presence of renal dysfunction and in the presence of increased inflammation (data not shown).
Finally, the ability of this five-variable model for predicting death was relatively high, with an area under the receiver operating characteristic curve of 0.71 ± 0.04 (data not shown).
Discussion
This study was the first prospective investigation in a very old population, in which arterial stiffness was measured and related to prognosis in conjunction with specific geriatric confounders. We showed that, in this very aged population, although marginally significant in crude analysis, PWV is a powerful determinant of prognosis after considering inflammation and denutrition.
Denutrition and prognosis
The association between low BMI and mortality has been reported previously in the elderly. 26, 27 Aging is variably associated with a progressive decrease in muscle mass and a relative increase in fat mass, 28 both of which are independently associated with mortality. 29 Recent weight loss, which could not be ascertained in our study, may reflect chronic disease or malnutrition, and confound the expected association between mortality and BMI.
A recent report suggested that the increase in the risk of death associated with a low BMI is driven primarily by respiratory and other causes, whereas the increased risk associated with a high BMI is driven by CV causes and cancer. 30 In our population, it was not possible to determine precisely the cause of death as invasive explorations were rarely performed for ethical reasons.
Inflammation and prognosis
Inflammation has an important role in both aging and chronic disease. Aging is characterized by chronic low-grade inflammation, 31 and a growing body of evidence suggests that inflammatory derangements are associated with unfavorable prognosis in the elderly. Several markers of inflammations, such as C-reactive protein, orosomucoide, a-1 acid glycoprotein and interleukin-6, [32] [33] [34] [35] have emerged as strong predictors of all-cause mortality in the aging population. In our population, orosomucoid was more closely related to all-cause mortality than C-reactive protein, leukocyte count or sedimentation rate.
Arterial stiffness and prognosis
For the present study, we used PWV as a marker of aortic stiffness because it is related to the square root of the aortic elasticity modulus and to the thickness-radius ratio. 36 The PWV, determined from the foot-to-foot transit time in the aorta, offers a simple, reproducible and non-invasive evaluation of regional arterial stiffness. This non-invasive, superficial measurement merely estimates the distance traveled by the pulse, and accurate measurements of this distance can only be obtained with invasive procedures. Regarding subjects 470 years of age, because arteries become longer and more convoluted, the path lengths determined from superficial linear measurements are obviously underestimated. Furthermore, aortic PWV may be considered a more reliable index than SBP itself, owing to the frequency of 'pseudo-hypertension' in this elderly population. 37 The major finding of the present study was that PWV was a predictor of overall mortality, after taking into account inflammation and denutrition. Interestingly, in the present elderly population, BP and particularly SBP and PP did not influence CV mortality. This finding raises the question as to Aortic stiffness and death in the oldest J Blacher et al whether BP (mainly SBP or PP), aortic stiffness or even a combination of both might be the best therapeutic target to reduce CV mortality in the elderly. 38 In patients with end-stage renal disease undergoing hemodialysis, Guerin et al. 39 have shown that for the same MBP reduction under drug treatment, PWV was reduced in survivors but remained unmodified in deceased patients. It is noteworthy that in such patients, hypertension has the same clinical features as in the elderly, involving increased aortic stiffness and a disproportionate elevation of SBP over DBP. 1, 2 Furthermore, the predictive value of several CV risk factors decreases with age because of selective survival and the influence of comorbidity on risk factors levels. 40, 41 By contrast, vascular stiffness increases steadily with age and could be considered a cumulative measure of previous exposures.
Considerations on the population
This population carries many particularities, which need to be detailed. First, and because of the inclusion criteria, there was a high prevalence of patent CV disease: Coronary, cerebral and peripheral vascular diseases affect approximately 62% of all patients. Second, this population was also extremely old: Only 80 subjects were o80 years of age, and 131 were 490 years old (mean age: 85.1 years; range: 70-103 years). This major trait might be responsible for a number of CV particularities, not particularly related to atherosclerosis, but more to 'physiological' CV aging. Third, carotid femoral PWV was consistently augmented, over-passing the 20 m s À1 in almost 10% of the population (mean PWV 14.4 m s À1 (7.2-28.9). We have shown in the past that, over 70 years of age, PWV no longer correlated with age. 42 Taken together, these findings suggest that the overall population was composed mainly of 'survivors'. 43 Our population is composed of very old institutionalized subject, with a characteristic risk profile. This makes our results hardly referable to different setting populations, like younger individuals, extremely old aged people and non-hospitalized populations. As mortality risks are different in institutionalized and noninstitutionalized elderly population, the determinants of mortality could be different in those two groups.
Our negative results concerning the prediction of mortality by systolic and PP are important to consider. Previous study in the oldest old reported this absence of relation between SBP and overall mortality. 7 One could consider that patients with more severe hypertension had probably died before having the 'age opportunity' of entering this study. The remaining poorly controlled hypertensives in this survey could benefit of a survival effect. Similar explanation could be given for PP.
Perspectives
In our elderly cohort, a trend was observed between carotid-femoral PWV and mortality risk in crude analysis. Multivariate Cox regression analysis showed that five parameters entered the prediction model: two were positively related to mortality risk, arterial stiffness and orosomucoide, and three were related negatively, total cholesterol, albumin and weight. Although a relation between arterial stiffness measured as PWV was not positively, strongly and linearly associated with mortality risk, mainly because of survival effect, vascular stiffness increases steadily with age and could be considered a cumulative measure of previous exposures.
In conclusion, we showed that in the frail oldest old with a high burden of CV disease, although marginally significant in crude analysis, PWV was a powerful determinant of prognosis in the oldest people after considering inflammation and denutrition.
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